See more : Embracer Group AB (publ) (0GFE.L) Income Statement Analysis – Financial Results
Complete financial analysis of QuantRx Biomedical Corporation (QTXB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of QuantRx Biomedical Corporation, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- 3-D Matrix, Ltd. (7777.T) Income Statement Analysis – Financial Results
- Sirio Pharma Co., Ltd. (300791.SZ) Income Statement Analysis – Financial Results
- Xiamen Port Development Co., Ltd. (000905.SZ) Income Statement Analysis – Financial Results
- Babcock & Wilcox Enterprises, Inc. (BW-PA) Income Statement Analysis – Financial Results
- DTE Energy Company (0I6Q.L) Income Statement Analysis – Financial Results
QuantRx Biomedical Corporation (QTXB)
Industry: Medical - Instruments & Supplies
Sector: Healthcare
About QuantRx Biomedical Corporation
QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 156.00 | 2.43K | 6.11K | 15.24K | 19.09K | 1.49M | 2.55M | 624.50K | 747.12K | 91.46K | 55.65K | 66.36K | 44.43K | 0.00 | 10.00K | 30.00K | 70.00K | 420.00K | 90.00K | 190.00K | 50.00K | 0.00 |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.86K | 7.17K | 9.67K | 1.98K | 586.00 | 346.00 | 409.00 | 375.00 | 27.85K | 61.90K | 4.06K | 0.00 | 285.82K | 102.03K | 0.00 | 0.00 | 130.00K | 230.00K | 270.00K | 500.00K | 160.00K | 70.00K | 40.00K | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -10.86K | -7.17K | -9.51K | 452.00 | 5.53K | 14.89K | 18.68K | 1.49M | 2.52M | 562.60K | 743.06K | 91.46K | -230.17K | -35.67K | 44.43K | 0.00 | -120.00K | -200.00K | -200.00K | -80.00K | -70.00K | 120.00K | 10.00K | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -6,095.51% | 18.60% | 90.41% | 97.73% | 97.86% | 99.97% | 98.91% | 90.09% | 99.46% | 100.00% | -413.64% | -53.75% | 100.00% | 0.00% | -1,200.00% | -666.67% | -285.71% | -19.05% | -77.78% | 63.16% | 20.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.15K | 65.74K | 27.92K | 24.89K | 47.87K | 1.54M | 2.32M | 2.03M | 2.01M | 665.64K | 136.86K | 0.00 | 0.00 | 0.00 | 230.00K | 790.00K | 1.07M | 990.00K | 670.00K | 250.00K | 0.00 | 0.00 |
General & Administrative | 0.00 | 43.38K | 60.62K | 201.74K | 235.88K | 154.32K | 56.23K | 336.05K | 387.53K | 345.39K | 473.95K | 733.69K | 768.66K | 2.50M | 3.85M | 4.26M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 540.00K | 900.00K | 1.22M | 3.55M | 3.29M | 4.22M | 4.12M | 1.05M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 75.43K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.12M | 10.12K | 94.60K | 244.96K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 43.38K | 60.62K | 201.74K | 235.88K | 154.32K | 131.67K | 336.05K | 387.53K | 345.39K | 473.95K | 733.69K | 1.89M | 2.51M | 3.95M | 4.50M | 2.42M | 694.04K | 50.69K | 37.47K | 55.00K | 540.00K | 900.00K | 1.22M | 3.55M | 3.29M | 4.22M | 4.12M | 1.05M |
Other Expenses | 0.00 | 0.00 | 24.61K | 0.00 | 100.26K | 4.68K | 82.61K | 9.67K | 9.67K | 9.18K | 10.34K | 33.89K | 1.19M | 20.80K | 4.23M | 4.72M | 2.44M | 700.99K | 55.52K | 94.50K | 119.27K | -10.00K | 0.00 | 10.00K | -10.00K | -10.00K | 0.00 | 0.00 | 0.00 |
Operating Expenses | 0.00 | 43.38K | 60.62K | 201.74K | 235.88K | 165.17K | 138.84K | 358.87K | 462.93K | 382.49K | 509.18K | 815.44K | 3.50M | 4.93M | 6.26M | 6.73M | 3.10M | 837.85K | 55.52K | 94.50K | 119.27K | 760.00K | 1.69M | 2.30M | 4.53M | 3.95M | 4.47M | 4.12M | 1.05M |
Cost & Expenses | 0.00 | 43.38K | 60.62K | 201.74K | 235.88K | 165.17K | 138.84K | 358.87K | 464.91K | 383.07K | 509.52K | 815.85K | 3.50M | 4.96M | 6.32M | 6.74M | 3.10M | 1.12M | 157.55K | 94.50K | 119.27K | 890.00K | 1.92M | 2.57M | 5.03M | 4.11M | 4.54M | 4.16M | 1.05M |
Interest Income | 0.00 | 216.66 | 216.72 | 198.18 | 1.13K | 0.00 | 0.00 | 0.00 | 4.38K | 13.71K | 16.00K | 16.00K | 22.02K | 40.10K | 22.62K | 76.57K | 44.22K | 8.72K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 216.66K | 216.72K | 198.18K | 232.17K | 245.41K | 196.15K | 123.90K | 104.69K | 95.96K | 141.00K | 6.50K | 7.64K | 465.03K | 369.90K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -40.00K | -20.00K | -60.00K | -60.00K | 20.00K | 10.00K | -270.00K | 0.00 |
Depreciation & Amortization | 228.49K | 43.38K | 60.62K | 201.74K | 10.86K | 10.86K | 7.17K | 9.67K | 9.67K | 9.18K | 10.34K | 33.89K | 60.61K | 92.48K | 283.44K | 294.60K | 4.46M | 37.64K | 4.83K | 4.83K | 53.58K | 70.00K | 100.00K | 130.00K | 160.00K | 150.00K | 150.00K | 90.00K | 20.00K |
EBITDA | 0.00 | -43.38K | -36.01K | -201.74K | -225.02K | -154.32K | -194.68K | -349.04K | -475.10K | -289.81K | -579.72K | -487.76K | -4.82M | -2.60M | -5.82M | -5.69M | 1.45M | -1.03M | -86.36K | -45.25K | -60.93K | -840.00K | -1.74M | -2.42M | -4.53M | -1.82M | -4.17M | -4.38M | -1.03M |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -228,337.82% | -19,551.48% | -4,369.82% | -3,071.34% | -3,913.44% | -322.49% | -128.30% | -565.97% | -702.16% | 1,582.29% | -1,851.70% | -237.63% | -110.09% | 0.00% | -8,400.00% | -5,800.00% | -3,457.14% | -1,078.57% | -2,022.22% | -2,194.74% | -8,760.00% | 0.00% |
Operating Income | 0.00 | -43.38K | -60.62K | -201.74K | -235.88K | -165.17K | -138.84K | -358.71K | -462.48K | -376.96K | -494.29K | -796.77K | -2.00M | -2.40M | -5.70M | -5.99M | -3.01M | -1.07M | -91.19K | -50.07K | -119.27K | -880.00K | -1.89M | -2.50M | -4.61M | -4.02M | -4.34M | -4.11M | -1.05M |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -229,941.67% | -19,032.18% | -6,166.55% | -3,244.21% | -4,174.82% | -134.22% | -94.23% | -912.69% | -801.50% | -3,292.41% | -1,919.34% | -137.40% | -112.70% | 0.00% | -8,800.00% | -6,300.00% | -3,571.43% | -1,097.62% | -4,466.67% | -2,284.21% | -8,220.00% | 0.00% |
Total Other Income/Expenses | 0.00 | -216.66K | -192.11K | -420.18K | -500.97K | 1.03M | -259.16K | -109.07K | -364.50K | 18.63K | -223.68K | 242.45K | 2.90M | -749.48K | -2.02M | -474.23K | -4.68M | -24.54K | 71.34K | 3.67K | -4.76K | 10.00K | 70.00K | 10.00K | -20.00K | 2.03M | 10.00K | -90.00K | 0.00 |
Income Before Tax | 0.00 | -260.04K | -252.73K | -621.92K | -736.85K | 869.14K | -397.99K | -467.78K | -826.99K | -358.33K | -717.97K | -554.32K | 831.19M | -3.15M | -7.72M | -6.46M | -7.69M | -1.09M | -19.84K | -46.41K | -124.03K | -870.00K | -1.82M | -2.49M | -4.63M | -1.99M | -4.33M | -4.20M | -1.05M |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -299,858.97% | -34,032.30% | -5,861.79% | -4,712.31% | -2,904.47% | 55,647.10% | -123.60% | -1,236.42% | -864.98% | -8,410.52% | -1,963.44% | -29.90% | -104.45% | 0.00% | -8,700.00% | -6,066.67% | -3,557.14% | -1,102.38% | -2,211.11% | -2,278.95% | -8,400.00% | 0.00% |
Income Tax Expense | 0.00 | 216.66K | 216.72K | 198.18K | 601.23K | 1.28M | 196.15K | 123.90K | 104.69K | 182.90K | 141.00K | 235.80K | -2.89M | -536.94K | 3.48M | 56.17K | 243.71K | -6.15K | -71.34K | -3.67K | 4.76K | -30.00K | 50.00K | -50.00K | -80.00K | 2.05M | 20.00K | -360.00K | 0.00 |
Net Income | 0.00 | -476.70K | -469.45K | -820.10K | -736.85K | 869.14K | -397.99K | -467.78K | -826.99K | -358.33K | -717.97K | -783.62K | 831.19K | -3.15M | -7.72M | -6.04M | -7.69M | -1.09M | -19.84K | -46.41K | -124.03K | -870.00K | -1.82M | -2.49M | -4.63M | -1.99M | -4.33M | -4.20M | -1.05M |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -299,858.97% | -34,032.30% | -5,861.79% | -4,712.31% | -4,105.93% | 55.65% | -123.60% | -1,236.42% | -809.02% | -8,410.52% | -1,963.44% | -29.90% | -104.45% | 0.00% | -8,700.00% | -6,066.67% | -3,557.14% | -1,102.38% | -2,211.11% | -2,278.95% | -8,400.00% | 0.00% |
EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | 0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | 0.01 | -0.07 | -0.18 | -0.15 | -0.26 | -0.07 | 0.00 | 0.00 | -0.01 | -0.09 | -0.19 | -0.26 | -0.38 | -0.17 | -0.47 | -0.52 | -0.21 |
EPS Diluted | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | 0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | 0.01 | -0.07 | -0.18 | -0.15 | -0.26 | -0.07 | 0.00 | 0.00 | -0.01 | -0.09 | -0.19 | -0.26 | -0.38 | -0.17 | -0.47 | -0.52 | -0.21 |
Weighted Avg Shares Out | 0.00 | 78.70M | 78.70M | 78.70M | 78.70M | 78.70M | 74.25M | 66.83M | 58.81M | 52.56M | 50.09M | 47.00M | 44.43M | 43.68M | 42.13M | 40.63M | 29.63M | 15.73M | 13.91M | 10.72M | 10.22M | 9.91M | 9.58M | 9.52M | 12.18M | 11.68M | 9.18M | 8.01M | 4.95M |
Weighted Avg Shares Out (Dil) | 0.00 | 78.70M | 78.70M | 78.70M | 78.70M | 130.44M | 74.25M | 66.83M | 58.81M | 52.56M | 50.09M | 47.00M | 44.43M | 43.68M | 42.13M | 40.63M | 29.63M | 15.73M | 13.91M | 10.72M | 10.22M | 9.91M | 9.58M | 9.52M | 12.18M | 11.68M | 9.18M | 8.01M | 4.95M |
Source: https://incomestatements.info
Category: Stock Reports